Immunocore Holdings plc (IMCR) Operating margin 2021–2025
Immunocore Holdings plc (IMCR) operating margin by fiscal year — reported operating income divided by reported revenue.
-11.3%FY2025 · since FY2021: -4281.2% → -11.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -11.3% | +11.4 pp |
| FY2024 | -22.7% | +1.2 pp |
| FY2023 | -23.9% | +5.7 pp |
| FY2022 | -29.7% | +4251.5 pp |
| FY2021 | -4281.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More IMCR financial trends
IMCR RevenueIMCR Net incomeIMCR Net marginIMCR Gross profitIMCR Gross marginIMCR Operating incomeIMCR Operating cash flowIMCR Free cash flowIMCR Capital expendituresIMCR Return on equityIMCR Stock buybacksIMCR Dividends paidIMCR Total assetsIMCR Total liabilitiesIMCR Shareholders’ equityIMCR overview →